Liquid Crystal Mixtures Including High Reliability Fluorinated Diluter and Reactive Monomer for Polymer Sustained Vertical Alignment and Polyimide-less Liquid Crystal Displays

作者: Okazaki, Tsuyoshi ; Okamoto, Kazuo ; Mizusaki, Masanobu ; Shibata, Toshihiro

In the case of polymer sustained vertical alignment (PSVA) and polyimide-less (PI-less) alignment technologies, polymer-alignment layers are formed by exposure of UV light to a liquid crystal (LC) layer including a LC composition and a reactive monomer.We were able to develop a high reliable fluorinated diluter for the LC composition toward the PSVA and the PI-less technologies.In addition, we also developed the PSVA and the PI-less in-plane switching mode LC cells with both fast response speed and high voltage holding ratio by combining the reactive monomer carrying a polarized UV absorption unit, chalcone.

2020-07-01·Journal of Photopolymer Science and Technology

Development of Long Lifetime and High Performance Organic Light Emitting Diode Display with Wide Temperature Range

作者: Tsuchiya, Hiroshi ; Shimada, Shinji ; Umeda, Tokiyoshi ; Mizusaki, Masanobu ; Tsukamoto, Yuto ; Shibasaki, Masakazu

A long lifetime organic light emitting diode (OLED) display at high temperature was developed with optimization of each layer organic materials.We clarified that chargecarrier balance between hole and electron inside the emission layer (EML) affects the lifetime of OLEDs, especially for blue-OLED.We also clarified that the lifetime becomes long with increasing the d. of hole in the EML.The lifetimes of the blue-, green, and red-OLEDs developed in this study were achieved over 1,000 h at 85°C under a driving of 600 cd/m² white luminance.A prototype 12.3 in. flexible OLED display was fabricated with using the new electron-blocking layer, hole-blocking layer, and hole-transport layer materials.We believe that the OLED display that we developed would be useful for automotive application.

2020-05-01·IEEE Transactions on Circuits and Systems for Video Technology

Tools for Video Coding Beyond HEVC: Flexible Partitioning, Motion Vector Coding, Luma Adaptive Quantization, and Improved Deblocking

作者: Andrew Segall ; Frank Bossen ; Kiran Misra

This paper provides a description and analysis of technology included in two contributions to the Call for Proposals for Video Compression with Capability beyond HEVC. This Call for Proposals was issued jointly by the Moving Picture Experts Group (MPEG) and the Video Coding Experts Group (VCEG). The contribution emphasized a flexible and rectangular partitioning structure, which was combined with both new and existing coding tools. New coding tools included methods for improved motion vector coding, quantization signaling, and deblocking; while existing tools were largely methods studied in the Joint Exploration Model software. Results show the efficacy of the approach. Using the sequences and test conditions defined in the Call for Proposals, the described approach provided an average bitrate reduction, relative to an HEVC anchor, of 41.2% and 35.7% for 4K and HD test sequences, respectively. Moreover, the method achieved a compression performance of 34.3% and 32.2% for high dynamic range content using the perceptual quantizer (PQ) and Hybrid-Log Gamma transfer functions, respectively.

项与 Sharp Packaging Solution Corp. 相关的新闻（医药）

2024-03-20

·PRNewswire

Systech Launches Innovative Exception Handling and Rework Solution

DOWNERS GROVE, Ill., March 20, 2024 /PRNewswire/ -- Systech, part of Markem-Imaje and Dover and a leading provider of digital identification and traceability software solutions, today announced that it has released a comprehensive and versatile rework offering for managing exceptions in the pharmaceutical supply chain. Built with Systech's extensive expertise, this new solution delivers robust capabilities from the assembly line through the supply chain to help manufacturers and distributors minimize data misalignment, product delays and associated risks in the pharmaceutical sector. "Our new feature-rich, exception handling solution addresses a diverse set of use cases, leveraging our vast experience in providing rework up and down the stack and ensuring seamless connectivity with trading partners," said Sreedhar Patnala, Vice President of Digital Products at Systech. "Systech's highly reliable and scalable solutions effectively mitigate risk and keep data and product moving." As trading partners continue to implement and fine-tune their processes to adhere to the Drug Quality and Security Act, the volume of errors related to discrepancies between the data and product received is expected to grow. Considering the increasing challenges related to counterfeits, drug shortages and patient safety, efficient handling of exceptions has become imperative. Key benefits of Systech's exception handling and rework solution include: Quick path to compliance with the Electronic Product Code Information Services checker, which serves as a built-in data inspector and reduces time to check and reconcile the data. Avoidance of product quarantine and supply chain delays with a communication hub that automates notifications to trading partners and regulatory authorities. High efficiency via multi-scan and mobile flexibility to optimize production and resolution time. As a full-stack solution provider, Systech uniquely offers a comprehensive rework solution with rapid deployment, seamless connectivity to any Level 4 platform and a built-in data inspector with the flexibility to adapt to any workflow and ecosystem. "The pharmaceutical industry must prioritize efficient exception handling and rework solutions to maintain product quality, patient safety and supply chain integrity," said Rick Seibert, SVP of Sharp Packaging, a leader in pharmaceutical packaging, clinical trial supply services & small-scale sterile manufacturing. "As a full-stack L1-L5 provider, Systech leverages its solution to streamline data from all sites and handles rework using a simple, cloud-based tool with no adverse impact on production." About Systech: Systech provides digital identification and traceability solutions that establish essential product data, ensure digital connectivity, and enable real-time insights on the packaging line and throughout the supply chain. With decades of experience in pharmaceutical packaging execution and serialization, Systech offers comprehensive, easily configured, turnkey software solutions with reliable implementation and expert support. Global brands across industries rely on Systech's platform to help them achieve their objectives in compliance, resiliency, sustainability, and digital transformation. Systech is a leading brand of Markem-Imaje®, a global product identification, packaging intelligence, and connected product solutions provider and a part of Dover Corporation. Visit for further information. About Markem-Imaje: Markem-Imaje, a wholly owned subsidiary of the US-based Dover Corporation is a trusted world manufacturer of product identification and traceability solutions, offering a full line of reliable and innovative inkjet, thermal transfer, laser, and print and apply label systems. Markem-Imaje provides global reach to over 50,000 customers with 30 subsidiaries, 6 technology centers, several equipment repair centers and manufacturing plants with the most comprehensive marking and coding portfolio available in the marketplace. Visit for further information. About Dover: Dover is a diversified global manufacturer and solutions provider with annual revenue of over $8 billion. We deliver innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services through five operating segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions and Climate & Sustainability Technologies. Dover combines global scale with operational agility to lead the markets we serve. Recognized for our entrepreneurial approach for over 65 years, our team of over 25,000 employees takes an ownership mindset, collaborating with customers to redefine what's possible. Headquartered in Downers Grove, Illinois, Dover trades on the New York Stock Exchange under "DOV." Additional information is available at dovercorporation.com. Systech Contact: Ameeta Soni (609) 395-8400 [email protected] Dover Media Contact: Adrian Sakowicz, VP, Communications     (630) 743-5039     [email protected]      Dover Investor Contact: Jack Dickens, Senior Director, Investor Relations (630) 743-2566 [email protected] SOURCE Dover

2023-03-21

·Pharmaceutical Technology

CMO Moves: Regulatory catalysts for drug manufacturing – March 2023

Image Credit: Shutterstock/Cergios The biotech industry is currently undergoing a wider financial upheaval after the collapse of Silicon Valley Bank (SVB) , which was favoured by many biotech companies. In such turbulent times, ensuring the most efficient and cost-effective manufacturing frameworks becomes even more important. Most pharmaceutical and biotech companies outsource certain production tasks to contract manufacturing organizations (CMOs). Based on the individual contract, these CMOs manufacture small molecules or biological active pharmaceutical ingredients (APIs), as well as packaging material, and are charged with other related functions. Free Report How is the Biopharmaceutical industry evolving? 2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects. Access the report to: Benchmark the impact of major themes on the Biopharmaceutical industry. Gain a deeper "on the ground" perspective through exclusive opinions and analysis from industry respondents. Evaluate the effects of COVID-19 on the sector. Download the full report to understand what to expect and how to align your strategies for success. By GlobalData Submit Country Code UK (+44) USA (+1) Algeria (+213) Andorra (+376) Angola (+244) Anguilla (+1264) Antigua & Barbuda (+1268) Argentina (+54) Armenia (+374) Aruba (+297) Australia (+61) Austria (+43) Azerbaijan (+994) Bahamas (+1242) Bahrain (+973) Bangladesh (+880) Barbados (+1246) Belarus (+375) Belgium (+32) Belize (+501) Benin (+229) Bermuda (+1441) Bhutan (+975) Bolivia (+591) Bosnia Herzegovina (+387) Botswana (+267) Brazil (+55) Brunei (+673) Bulgaria (+359) Burkina Faso (+226) Burundi (+257) Cambodia (+855) Cameroon (+237) Canada (+1) Cape Verde Islands (+238) Cayman Islands (+1345) Central African Republic (+236) Chile (+56) China (+86) Colombia (+57) Comoros (+269) Congo (+242) Cook Islands (+682) Costa Rica (+506) Croatia (+385) Cuba (+53) Cyprus North (+90392) Cyprus South (+357) Czech Republic (+42) Denmark (+45) Djibouti (+253) Dominica (+1809) Dominican Republic (+1809) Ecuador (+593) Egypt (+20) El Salvador (+503) Equatorial Guinea (+240) Eritrea (+291) Estonia (+372) Ethiopia (+251) Falkland Islands (+500) Faroe Islands (+298) Fiji (+679) Finland (+358) France (+33) French Guiana (+594) French Polynesia (+689) Gabon (+241) Gambia (+220) Georgia (+7880) Germany (+49) Ghana (+233) Gibraltar (+350) Greece (+30) Greenland (+299) Grenada (+1473) Guadeloupe (+590) Guam (+671) Guatemala (+502) Guinea (+224) Guinea - Bissau (+245) Guyana (+592) Haiti (+509) Honduras (+504) Hong Kong (+852) Hungary (+36) Iceland (+354) India (+91) Indonesia (+62) Iran (+98) Iraq (+964) Ireland (+353) Israel (+972) Italy (+39) Jamaica (+1876) Japan (+81) Jordan (+962) Kazakhstan (+7) Kenya (+254) Kiribati (+686) Korea North (+850) Korea South (+82) Kuwait (+965) Kyrgyzstan (+996) Laos (+856) Latvia (+371) Lebanon (+961) Lesotho (+266) Liberia (+231) Libya (+218) Liechtenstein (+417) Lithuania (+370) Luxembourg (+352) Macao (+853) Macedonia (+389) Madagascar (+261) Malawi (+265) Malaysia (+60) Maldives (+960) Mali (+223) Malta (+356) Marshall Islands (+692) Martinique (+596) Mauritania (+222) Mayotte (+269) Mexico (+52) Micronesia (+691) Moldova (+373) Monaco (+377) Mongolia (+976) Montserrat (+1664) Morocco (+212) Mozambique (+258) Myanmar (+95) Namibia (+264) Nauru (+674) Nepal (+977) Netherlands (+31) New Caledonia (+687) New Zealand (+64) Nicaragua (+505) Niger (+227) Nigeria (+234) Niue (+683) Norfolk Islands (+672) Northern Marianas (+670) Norway (+47) Oman (+968) Palau (+680) Panama (+507) Papua New Guinea (+675) Paraguay (+595) Peru (+51) Philippines (+63) Poland (+48) Portugal (+351) Puerto Rico (+1787) Qatar (+974) Reunion (+262) Romania (+40) Russia (+7) Rwanda (+250) San Marino (+378) Sao Tome & Principe (+239) Saudi Arabia (+966) Senegal (+221) Serbia (+381) Seychelles (+248) Sierra Leone (+232) Singapore (+65) Slovak Republic (+421) Slovenia (+386) Solomon Islands (+677) Somalia (+252) South Africa (+27) Spain (+34) Sri Lanka (+94) St. Helena (+290) St. Kitts (+1869) St. Lucia (+1758) Sudan (+249) Suriname (+597) Swaziland (+268) Sweden (+46) Switzerland (+41) Syria (+963) Taiwan (+886) Tajikstan (+7) Thailand (+66) Togo (+228) Tonga (+676) Trinidad & Tobago (+1868) Tunisia (+216) Turkey (+90) Turkmenistan (+7) Turkmenistan (+993) Turks & Caicos Islands (+1649) Tuvalu (+688) Uganda (+256) Ukraine (+380) United Arab Emirates (+971) Uruguay (+598) Uzbekistan (+7) Vanuatu (+678) Vatican City (+379) Venezuela (+58) Vietnam (+84) Virgin Islands - British (+1284) Virgin Islands - US (+1340) Wallis & Futuna (+681) Yemen (North)(+969) Yemen (South)(+967) Zambia (+260) Zimbabwe (+263) Country UK USA Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Congo Democratic Republic of the Congo Cook Islands Costa Rica Côte d"Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kuwait Kyrgyzstan Lao Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russian Federation Rwanda Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and The Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and The South Sandwich Islands Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates US Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam British Virgin Islands US Virgin Islands Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Kosovo Submit By clicking the Download Free Report button, you accept the terms and conditions and acknowledge that your data will be used as described in the GlobalData privacy policy By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services. Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. Thank you. Please check your email to download the Report. The ongoing monthly CMO Moves series is outlining the relationship between pharmaceutical and biotech companies, and CMOs using recent news events and clinical trial catalysts. In this month’s edition, which covers events from late January to early March, manufacturing contract-related data from GlobalData’s PharmSource reports and news from GlobalData’s Pharma Intelligence Center have been collated to identify stakeholders at the center of new developments. FDA and EMA decisions In January, the European Commission (EC) approved Roche’s Xofluza (baloxavir marboxil) to prevent and treat influenza in children ages one year and older. Sharp Packaging Services is producing the solid dose of the drug and packaging it. A few weeks later, the EC extended the approval label of AstraZeneca’s Forxiga (dapagliflozin) to include the treatment of symptomatic hearth failure. The SGLT2 inhibitor is already approved to treat type 2 diabetes (T2D), chronic kidney disease (CKD), and heart failure with reduced ejection fraction (HFrEF) in patients with or without T2D. Bristol Myers Squibb is in charge of the solid dose manufacturing, while Catalent is doing the solid dose production and packaging. SK Biotek is contracted to manufacture the small molecule API. In early February, the FDA approved Regeneron Pharmaceuticals’ Eylea (aflibercept) injection to treat the rare disorder retinopathy of prematurity (ROP) in preterm infants. Vetter Pharma-Fertigung GmbH & Co KG is contracted for the parenteral manufacture and packaging for the vascular endothelial growth factor (VEGF) inhibitor, while Biogen and KBI Biopharma are producing the biologic API. The US agency also extended the approval of Gilead Sciences’ Trodelvy (sacituzumab govitecan-hziy) to include the treatment of HR-positive HER2-negative breast cancer patients after endocrine-based therapy and at least two systemic therapies . Samsung Biologics is producing the biologic API, while BSP Pharmaceuticals SpA is manufacturing the biologic API and the parenteral portions of the antibody-drug conjugate. Regulatory decisions by the FDA and EMA for select therapies from late January to late February and the CMOs contracted to manufacture the therapies. Source: GlobalData Pharmaceutical Intelligence Center Regulatory and reimbursement decisions in the UK In late January, the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) granted a marketing authorization to Beigene’s Brukinsa (zanubrutinib) to treat chronic lymphocytic leukemia (CLL) and marginal zone lymphoma (MZL) after at least one prior anti-CD20-based therapy. While Catalent is in charge of the solid dose manufacturing for the small molecule, PCI Pharma Services is responsible for solid dose manufacturing and packaging. On February 1, the UK’s National Institute for Health and Care Excellence ( Nice ) published a recommendation to cover Daiichi Sankyo and AstraZeneca ’s antibody-drug conjugate (ADC) Enhertu (deruxtecan) to treat HER2-positive metastatic breast cancer after one or more anti-HER2 treatments. Later that month, China’s National Medical Products Administration (NMPA) also granted an approval for the same indication . Baxter Biopharma Solutions is contracted for the parenteral manufacture and packaging of Enhertu. Regulatory decisions by the UK’s MHRA and NICE for select therapies from late January to late February and the CMOs contracted to manufacture the therapies. Source: GlobalData Pharmaceutical Intelligence Center Clinical trial catalysts In late January, AC Immune released positive interim results from the Phase I/II trial (NCT05462106) studying the company’s vaccine in patients with prodromal Alzheimer’s disease. The vaccine ACI-24.060 elicited an anti-Abeta antibody response in the first patient cohort after six weeks, as per the results. Bachem Holding and Polymun Scientific Immunbiologische Forschung GmbH are contracted for the parenteral manufacturing, while WuXi Biologics Caymanis producing the biologic API. In the same time period, Warren, New Jersey-based Tevogen Bio released positive data from a trial evaluating its allogeneic T cell therapy TVGN 489, which is meant to treat high-risk COVID-19. The study was conducted at Thomas Jefferson University Hospital in Philadelphia evaluated the therapy in 12 ambulatory patients. BioCentriq is contracted to manufacture the biologic API. Clinical trial catalysts announced for select therapies from late January to late February and the CMOs contracted to manufacture the therapies. Source: GlobalData Pharmaceutical Intelligence Center To re ad the previous editions in this series, click here, and here. Free Report How is the Biopharmaceutical industry evolving? 2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects. Access the report to: Benchmark the impact of major themes on the Biopharmaceutical industry. Gain a deeper "on the ground" perspective through exclusive opinions and analysis from industry respondents. Evaluate the effects of COVID-19 on the sector. Download the full report to understand what to expect and how to align your strategies for success. By GlobalData Submit Country Code UK (+44) USA (+1) Algeria (+213) Andorra (+376) Angola (+244) Anguilla (+1264) Antigua & Barbuda (+1268) Argentina (+54) Armenia (+374) Aruba (+297) Australia (+61) Austria (+43) Azerbaijan (+994) Bahamas (+1242) Bahrain (+973) Bangladesh (+880) Barbados (+1246) Belarus (+375) Belgium (+32) Belize (+501) Benin (+229) Bermuda (+1441) Bhutan (+975) Bolivia (+591) Bosnia Herzegovina (+387) Botswana (+267) Brazil (+55) Brunei (+673) Bulgaria (+359) Burkina Faso (+226) Burundi (+257) Cambodia (+855) Cameroon (+237) Canada (+1) Cape Verde Islands (+238) Cayman Islands (+1345) Central African Republic (+236) Chile (+56) China (+86) Colombia (+57) Comoros (+269) Congo (+242) Cook Islands (+682) Costa Rica (+506) Croatia (+385) Cuba (+53) Cyprus North (+90392) Cyprus South (+357) Czech Republic (+42) Denmark (+45) Djibouti (+253) Dominica (+1809) Dominican Republic (+1809) Ecuador (+593) Egypt (+20) El Salvador (+503) Equatorial Guinea (+240) Eritrea (+291) Estonia (+372) Ethiopia (+251) Falkland Islands (+500) Faroe Islands (+298) Fiji (+679) Finland (+358) France (+33) French Guiana (+594) French Polynesia (+689) Gabon (+241) Gambia (+220) Georgia (+7880) Germany (+49) Ghana (+233) Gibraltar (+350) Greece (+30) Greenland (+299) Grenada (+1473) Guadeloupe (+590) Guam (+671) Guatemala (+502) Guinea (+224) Guinea - Bissau (+245) Guyana (+592) Haiti (+509) Honduras (+504) Hong Kong (+852) Hungary (+36) Iceland (+354) India (+91) Indonesia (+62) Iran (+98) Iraq (+964) Ireland (+353) Israel (+972) Italy (+39) Jamaica (+1876) Japan (+81) Jordan (+962) Kazakhstan (+7) Kenya (+254) Kiribati (+686) Korea North (+850) Korea South (+82) Kuwait (+965) Kyrgyzstan (+996) Laos (+856) Latvia (+371) Lebanon (+961) Lesotho (+266) Liberia (+231) Libya (+218) Liechtenstein (+417) Lithuania (+370) Luxembourg (+352) Macao (+853) Macedonia (+389) Madagascar (+261) Malawi (+265) Malaysia (+60) Maldives (+960) Mali (+223) Malta (+356) Marshall Islands (+692) Martinique (+596) Mauritania (+222) Mayotte (+269) Mexico (+52) Micronesia (+691) Moldova (+373) Monaco (+377) Mongolia (+976) Montserrat (+1664) Morocco (+212) Mozambique (+258) Myanmar (+95) Namibia (+264) Nauru (+674) Nepal (+977) Netherlands (+31) New Caledonia (+687) New Zealand (+64) Nicaragua (+505) Niger (+227) Nigeria (+234) Niue (+683) Norfolk Islands (+672) Northern Marianas (+670) Norway (+47) Oman (+968) Palau (+680) Panama (+507) Papua New Guinea (+675) Paraguay (+595) Peru (+51) Philippines (+63) Poland (+48) Portugal (+351) Puerto Rico (+1787) Qatar (+974) Reunion (+262) Romania (+40) Russia (+7) Rwanda (+250) San Marino (+378) Sao Tome & Principe (+239) Saudi Arabia (+966) Senegal (+221) Serbia (+381) Seychelles (+248) Sierra Leone (+232) Singapore (+65) Slovak Republic (+421) Slovenia (+386) Solomon Islands (+677) Somalia (+252) South Africa (+27) Spain (+34) Sri Lanka (+94) St. Helena (+290) St. Kitts (+1869) St. Lucia (+1758) Sudan (+249) Suriname (+597) Swaziland (+268) Sweden (+46) Switzerland (+41) Syria (+963) Taiwan (+886) Tajikstan (+7) Thailand (+66) Togo (+228) Tonga (+676) Trinidad & Tobago (+1868) Tunisia (+216) Turkey (+90) Turkmenistan (+7) Turkmenistan (+993) Turks & Caicos Islands (+1649) Tuvalu (+688) Uganda (+256) Ukraine (+380) United Arab Emirates (+971) Uruguay (+598) Uzbekistan (+7) Vanuatu (+678) Vatican City (+379) Venezuela (+58) Vietnam (+84) Virgin Islands - British (+1284) Virgin Islands - US (+1340) Wallis & Futuna (+681) Yemen (North)(+969) Yemen (South)(+967) Zambia (+260) Zimbabwe (+263) Country UK USA Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Congo Democratic Republic of the Congo Cook Islands Costa Rica Côte d"Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kuwait Kyrgyzstan Lao Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russian Federation Rwanda Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and The Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and The South Sandwich Islands Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates US Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam British Virgin Islands US Virgin Islands Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Kosovo Submit By clicking the Download Free Report button, you accept the terms and conditions and acknowledge that your data will be used as described in the GlobalData privacy policy By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services. Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. Thank you. Please check your email to download the Report.

上市批准临床结果免疫疗法疫苗

2021-07-27

·GlobeNewswire

High Barrier Films Market for Food Packaging to Reach $30.8 billion by 2028 — Exclusive Report by Meticulous Research®

London, July 27, 2021 (GLOBE NEWSWIRE) -- According to a new market research report titled “High Barrier Films Market for Food Packaging by Material Type (PE, BOPP & BOPET, CPP, EVOH, Nylon), Technology, Application (Meat and Fish, Dairy, Snacks, Confectionery, Bakery Products, Pet Food), End User, and Geography - Global Forecast to 2028”, the high barrier films market for food packaging is expected to reach $30.8 billion by 2028, at a CAGR of 5.9% from 2021. Download Free Sample Report Now @ The growth of this market is mainly attributed to the inclination towards case-ready packaging products, rising need for high barrier packaging films for longer shelf-life, growing consumer concerns for food wastage reduction, and growing demand from the meat industry. Moreover, the growing demand for biodegradable high barrier packaging films is expected to create lucrative opportunities for high barrier film manufacturers in this market. However, susceptibility to degradation is expected to hinder the growth of this market to some extent. Sales of processed, canned, and frozen foods are rising as many consumers move away from fresh foods. Usually, the increasingly busy lifestyle of consumers and the consequent demand for convenient food packaging is driving the demand for barrier films. These high barrier films help to increase the product life and reduce the usage of preservatives. Barrier films also act as a printing substrate, which further provides aesthetic appeal to the product. As consumers become more aware of the impact their behavior has on the environment, they are increasingly interested in concrete ways to reduce their footprint. Now more than ever, consumers seek to purchase products that reflect their values and are sourced, produced, and packaged as sustainably as possible. Shelf life longevity is the key factor consumers are considering in recent years. COVID-19 has also escalated the demand for longer shelf-life products. UAE-headquartered fast-moving consumer goods (FMCG) firm Truebell has seen demand for long shelf-life products go up three folds due to the pandemic. According to Truebell, the company has seen an increase in the popularity of long-shelf-life food products and baking ingredients, increased consumption of home-cooked meals, more residents shopping locally, and rising interest in online food tutorials. In March 2020, Truebell witnessed a 300% increase in the demand for long shelf-life products. Consumers concerned about sustainable consumption welcome opportunities to purchase foods that offer a longer shelf life, and retailers are well-positioned to play a role in offering more sustainable solutions. Nowadays, the food & beverage industry is transferring from traditional packaging formats to lightweight and easy-to-transport packaging. Barrier films help cater to this demand as they are lightweight compared to rigid packaging and eliminate the use of glass and cans, which increase the weight of the packaging. In addition, the barrier film works to efficiently block oxygen transmission and water vapor from contacting sensitive foods. All these factors are expected to drive the growth of the high barrier films market for food packaging across the globe. Impact of COVID-19 on the High Barrier Films Market for Food Packaging The COVID-19 pandemic has disrupted all sectors, including the packaging industry. It has a negative impact on the packaging barrier films market, as the supply chain is disrupted and production has taken a hit with less workforce. Usually, stay-at-home directives in many countries have resulted in no production and have restrained demand for packaging as the sale of consumer goods has dipped. In addition, the fluctuating economic conditions and exchange rates also are affecting the cost of raw materials. Thus, the high impact of coronavirus on the food and beverage industry and food packaging industry somehow limits demand for high barrier films. Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: However, with many people buying groceries online amidst the pandemic, new habits could also form, with COVID-19 accelerating the take-up of food e-commerce. As a result, E-commerce is expected to continue expanding share over traditional retail channels. This results in rising demand for smart packaging, including high barrier films, and further accelerated by the COVID-19 pandemic. For instance, Carlsberg Brewery Malaysia is focusing on digital marketing and E-commerce to recover from huge revenue, and profit drops during the COVID-19 pandemic outbreak. In 2021, the demand for packaging barrier films is expected to gain momentum as the demand for frozen food and other food items with a longer shelf life is expected. In addition, the growing demand for food safety will drive a significant chunk of sales of packaging barrier films in 2021. Key Findings in the High Barrier Films Market for Food Packaging Study The overall high barrier films market for food packaging is segmented on the basis of material type (PE, BOPP and BOPET, CPP, EVOH, nylon, and other materials), technology (plasma-enhanced chemical vapor deposition (PECVD) and other technologies), application (meat and fish, dairy, snacks, beverages, dehydrated foods & cereals, bakery products, confectionery, pet food, and other food products), and end user (processed food manufacturers and suppliers, packaging service providers, and other end users). The study also evaluates industry competitors and analyzes the market at a regional and country level. Based on material type, the polyethylene (PE) segment is expected to account for the largest share of the overall high barrier films market for food packaging in 2021, owing to the growing concerns about the rising use of bioplastic materials, rising need to replace glass and metal with polyethylene films, and increased demand for hygienic and durable food packaging materials combined with consumer environmental concerns. Based on technology, the PECVD segment is expected to grow at the fastest CAGR during the forecast period due to factors such as low operation temperature, lower chances of cracking deposited layer, good dielectric properties of the deposited layer, decent step coverage, less temperature-dependency, and rising demand for packaged foods. Quick Buy – High Barrier Films Market for Food Packaging Research Report: Based on application, the meat and fish segment is expected to account for the largest share of the overall high barrier films market for food packaging in 2021. The large share and fastest growth of this segment is mainly attributed to the higher incomes and urbanization, rising consumption of processed meat products, rising global consumption of fish, and increasing consumer preference for protein-rich food products. Based on the end user, the processed food manufacturers and suppliers segment is expected to account for the largest share of the overall high barrier film market for food packaging in 2021, owing to the growing demand for processed food products and the increasing number of food processing units. Geographically, Asia-Pacific region is estimated to account for the largest share of the global high barrier films market for food packaging in 2021, followed by North America and Europe. The large share of this region is mainly attributed to the growing demand for processed food products; strong growth in the food & beverage industry due to increasing urbanization, rising health awareness, and rising disposable income levels; development of the cold chain systems; government support for food processing sector; and growing demand for pet food. Key Players Some of the prominent players operating in the global high barrier films market for food packaging are Amcor plc (Switzerland), Mondi plc (U.K.), Huhtamaki Group (Finland), Sealed Air Corporation (U.S.), Jindal Poly Films Limited (India), Toppan Printing Co., Ltd. (Japan), Kureha Corporation (Japan), HPM Global, Inc. (South Korea), Flair Flexible Packaging Corporation (U.S.), Constantia Flexibles Group GmbH (Austria), MULTIVAC (Germany), DuPont Teijin Films (U.S.), Wihuri Group (Finland), BERNHARDT Packaging & Process (France), Borealis AG (Austria), and Uflex Limited (India) among others. To gain more insights into the market with a detailed table of content and figures, click here: Scope of the Report: High Barrier Films Market for Food Packaging, by Material Type High Barrier Films Market for Food Packaging, by Technology High Barrier Films Market for Food Packaging, by Application High Barrier Films Market for Food Packaging, by End User High Barrier Films Market for Food Packaging, by Geography Download Free Sample Report Now @ Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- Related Report: Smart Packaging Market by Packaging Technology (Modified Atmosphere Packaging, Active Packaging {Ethanol Emitters}, Intelligent Packaging {Indicators}), by Application (Food and Beverages, Pharmaceuticals, Automotive), Geography - Global Forecast To 2027 About Meticulous Research® Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact: Mr. Khushal Bombe Meticulous Market Research Inc. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe : +44-203-868-8738 APAC: +91 744-7780008 Email- sales@meticulousresearch.com Visit Our Website: Connect with us on LinkedIn- Content Source:

100 项与 Sharp Packaging Solution Corp. 相关的药物交易

登录后查看更多信息

100 项与 Sharp Packaging Solution Corp. 相关的转化医学

登录后查看更多信息